Abstract | BACKGROUND: METHODS: RESULTS:
Silibinin suppressed the growth of HMC-1 cells and also reduced the production and mRNA expression of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-8. Moreover, silibinin inhibited the nuclear translocation of nuclear factor (NF)-κB through inhibition of the phosphorylation of IκBα and suppressed NF-κB transcriptional activity in stimulated HMC-1 cells. CONCLUSIONS: Taken together, these results indicate that silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast cells, suggesting that silibinin could be used for the treatment of mast cell-derived allergic inflammatory diseases.
|
Authors | Beom-Rak Kim, Hye-Sook Seo, Jin-Mo Ku, Gyung-Jun Kim, Chan Yong Jeon, Jong Hyeong Park, Bo-Hyoung Jang, Sun-Ju Park, Yong-Cheol Shin, Seong-Gyu Ko |
Journal | Inflammation research : official journal of the European Histamine Research Society ... [et al.]
(Inflamm Res)
Vol. 62
Issue 11
Pg. 941-50
(Nov 2013)
ISSN: 1420-908X [Electronic] Switzerland |
PMID | 24045679
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Allergic Agents
- Cytokines
- NF-kappa B
- RNA, Messenger
- Silymarin
- Silybin
- I-kappa B Kinase
|
Topics |
- Animals
- Anti-Allergic Agents
(pharmacology)
- Cell Line
- Cell Survival
(drug effects)
- Cytokines
(antagonists & inhibitors, genetics, metabolism)
- Humans
- I-kappa B Kinase
(metabolism)
- Mast Cells
(drug effects, metabolism)
- Mice
- NF-kappa B
(antagonists & inhibitors)
- RNA, Messenger
(metabolism)
- Silybin
- Silymarin
(pharmacology)
|